ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,842.00
4.57%
S&P 500
5,130.03
1.30%
Dow Jones
38,681.46
1.19%
US Dollar vs Yen
152.862
-0.12%
Brent Oil
82.81
-0.98%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) ニュース

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:PLX
日付受信時刻ニュースソース見出しコード企業名
2024/01/0220 : 36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
2023/12/2620 : 56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/11/3018 : 00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
2023/11/0621 : 50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2023/11/0621 : 22Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/11/0105 : 40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
2023/10/2019 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1605 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1605 : 45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1219 : 58Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/09/0619 : 50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1205 : 31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
2023/08/0720 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2023/08/0719 : 59Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/07/1405 : 41Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/07/0805 : 30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
2023/06/2920 : 25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
2023/06/2920 : 24Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/06/2905 : 30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
2023/06/2905 : 30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
2023/05/3020 : 24Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
2023/05/1906 : 08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:PLX

最近閲覧した銘柄

NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
FX
USDJPY
US Dollar vs Yen
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
FX
USDEUR
US Dollar vs Euro
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有